Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sex Transm Dis ; 33(8): 512-5, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16572040

RESUMO

OBJECTIVES: A sharp increase in the incidence of gonorrhea has been observed in Tel Aviv, Israel, since 1999. Almost one half of interviewed patients admitted contracting the infection from a sex worker. In two thirds of the cases, oral sex (fellatio) was the most probable route of acquiring the disease. In the current study, we assessed the prevalence of pharyngeal gonorrhea among sex workers in Tel Aviv and evaluated the efficacy of a single 2-g dose of azithromycin in eradicating the infection. METHODS: Throat specimens were obtained for gonococcal culture from 301 female sex workers practicing in brothels. A questionnaire covering demographic and sexual behavior information was administered to all participants, and a single 2-g dose was administered orally under supervision. Women with positive cultures were reexamined a week later for eradication of Neisseria gonorrhoeae. RESULTS: N gonorrhoeae was isolated from 27 women (9%). The median age of women with pharyngeal gonorrhea was 23 years (range, 18-32 years); 85% were born in former Soviet Union (mostly Russia, Ukraine, Moldavia). Regular condom use in vaginal sex was reported by 88% of the participants, whereas only 60% reported always using condoms in oral sex. All isolates were susceptible to azithromycin (MIC < or = 0.5 microg/ml). Gonococci were eradicated in 20/21 individuals (95%). CONCLUSION: A high carriage rate of gonococci in the throat and a low rate of condom use in oral sex were documented among sex workers in Tel Aviv. A single 2 g dose of azithromycin was very effective in eradicating gonococci from the throat.


Assuntos
Azitromicina/farmacologia , Gonorreia/tratamento farmacológico , Neisseria gonorrhoeae/efeitos dos fármacos , Doenças Faríngeas/tratamento farmacológico , Trabalho Sexual/estatística & dados numéricos , Adolescente , Adulto , Azitromicina/administração & dosagem , Azitromicina/uso terapêutico , Preservativos/estatística & dados numéricos , Surtos de Doenças , Feminino , Gonorreia/epidemiologia , Gonorreia/etiologia , Gonorreia/microbiologia , Humanos , Israel/epidemiologia , Testes de Sensibilidade Microbiana , Mucosa Bucal/microbiologia , Doenças Faríngeas/epidemiologia , Doenças Faríngeas/etiologia , Doenças Faríngeas/microbiologia , Prevalência , Comportamento Sexual , Inquéritos e Questionários
2.
Isr Med Assoc J ; 5(9): 629-32, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14509151

RESUMO

BACKGROUND: Vaginal symptoms are a leading reason for a patient to visit her gynecologist. Little is known about the prevalence of the different causes of vaginitis and the risk factors for this entity in Israel. OBJECTIVE: To determine the prevalence of the main forms of vaginitis: vulvovaginal candidiasis, bacterial vaginosis, and trichomoniasis, in a gynecologic practice in Israel. METHODS: We evaluated 208 patients presenting with vaginal symptoms to a gynecologic clinic; 100 asymptomatic women who attended the clinic for routine check-up served as controls. Demographic, medical and gynecologic histories were obtained, and a pelvic examination was performed in all patients. Vaginal specimens were tested for pH and amine reaction, smeared for Gram-staining and cultured for yeasts and Trichomonas vaginalis. Bacterial vaginitis was diagnosed using the Nugent scoring system. Candida infection was diagnosed by microscopic examination and by culture. RESULTS: Candida spp. was the most common pathogen, documented by microscopy and culture in 35.5% of symptomatic women and 15% of asymptomatic controls (P < 0.001). Detection by culture only (negative microscopy) was documented in 18.7% of symptomatic patients and 15% of controls (P = 0.5). Bacterial vaginosis (Nugent score > or = 7) was diagnosed in 23.5% of patients and 13% of controls (P = 0.04). Trichomoniasis was present in 8.1% of symptomatic women and 4% of controls (P = 0.1). The main risk factors were antibiotic use for candidiasis and lack of use of oral contraception and condom use for trichomoniasis. CONCLUSION: Candida was by far the most common pathogen detected in our population. A statistically significant difference between patients and controls was noted for the prevalence of microscopically diagnosed candidiasis and bacterial vaginosis.


Assuntos
Instituições de Assistência Ambulatorial/estatística & dados numéricos , Ginecologia/estatística & dados numéricos , Vaginite/epidemiologia , Adulto , Distribuição por Idade , Antibacterianos/uso terapêutico , Candida/isolamento & purificação , Candidíase Vulvovaginal/epidemiologia , Causalidade , Infecções por Chlamydia/epidemiologia , Comportamento Contraceptivo/estatística & dados numéricos , Feminino , Gonorreia/epidemiologia , Humanos , Israel/epidemiologia , Prevalência , Valores de Referência , Fatores de Risco , Vaginite por Trichomonas/epidemiologia , Vagina/microbiologia , Vaginose Bacteriana/epidemiologia
3.
Antimicrob Agents Chemother ; 46(6): 1671-3, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12019074

RESUMO

A survey of the drug susceptibilities of gonococcal isolates from 100 consecutive patients attending clinics in the Tel Aviv area of Israel during the period from February to September 2000 has shown a 61% rate of ciprofloxacin resistance (MICs, > or =1 microg/ml); 51 isolates were highly resistant (MICs, > or =4 microg/ml). Ciprofloxacin-resistant strains were more prevalent among isolates with chromosomally mediated resistance to penicillin and tetracycline. Therapeutic failures with ciprofloxacin correlated with MICs of > or =1 mg/ml (P < 0.01). The high rate of ciprofloxacin resistance coinciding with a sharp rise in the incidence of gonorrhea precludes the use of fluoroquinolone drugs for the empirical treatment of gonococcal infections acquired in Israel.


Assuntos
Anti-Infecciosos/farmacologia , Ciprofloxacina/farmacologia , Ciprofloxacina/uso terapêutico , Gonorreia/tratamento farmacológico , Gonorreia/epidemiologia , Neisseria gonorrhoeae/efeitos dos fármacos , Anti-Infecciosos/uso terapêutico , Resistência Microbiana a Medicamentos , Gonorreia/microbiologia , Humanos , Israel/epidemiologia , Testes de Sensibilidade Microbiana , Neisseria gonorrhoeae/enzimologia , Fenótipo , beta-Lactamases/análise , beta-Lactamases/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...